45 CFR 46

45 CFR 46
Title	45 CFR 46
Subject	Human subjects research protections
Jurisdiction	United States
Enacted	1974
Amended	various

45 CFR 46 is the federal regulatory framework for protections of human subjects in research funded or conducted by the United States Department of Health and Human Services, establishing requirements for institutional review, informed consent, and special protections for vulnerable populations. It codifies ethical principles arising from historical events and documents, and it interfaces with federal agencies, academic institutions, and healthcare organizations to govern research practices. Major revisions and harmonization efforts link it to other regulatory and ethical instruments that guide human subject protections across biomedical and social science research.

Overview

45 CFR 46 implements statutory mandates and interprets ethical guidance derived from landmark events and documents such as the Nuremberg Code, the Tuskegee Syphilis Study revelations, the Belmont Report, the National Research Act, and subsequent policy reforms influenced by agencies like the National Institutes of Health and the Food and Drug Administration. It establishes regulatory obligations for entities such as universities, medical centers, clinical research organizations, and federal agencies engaged in federally supported research, and it aligns with international instruments including the Declaration of Helsinki and the Council for International Organizations of Medical Sciences guidelines.

Key Provisions and Subparts

45 CFR 46 is organized into subparts that address general protections and additional safeguards: Subpart A sets baseline requirements for informed consent, risk–benefit assessment, and Institutional Review Board procedures; Subpart B provides protections for pregnant women, human fetuses, and neonates; Subpart C addresses research involving prisoners; and Subpart D focuses on protections for children. These subparts intersect with standards promulgated by bodies such as the Office for Human Research Protections, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, and agencies like the Centers for Disease Control and Prevention and the Agency for Healthcare Research and Quality.

Scope and Applicability

The regulation applies to research activities conducted or supported by entities under the oversight of the Department of Health and Human Services and often sets the floor for nonfederally funded research through institutional policies and grants administered by organizations such as the Howard Hughes Medical Institute, the Wellcome Trust, and the Gates Foundation. It delineates when human subjects research requires review, consent, and recordkeeping, and it interacts with statutes and regulations enforced by the Department of Justice, the Office of Management and Budget, and multinational frameworks like the European Medicines Agency guidelines when studies cross borders.

Institutional Review Boards (IRBs) and Compliance

The regulation mandates review by Institutional Review Boards, outlining IRB composition, quorum, conflicts of interest, continuing review, and documentation requirements; IRBs operate within institutions such as Harvard University, Johns Hopkins University, Mayo Clinic, and consortia like the Association of American Medical Colleges and the American Medical Association. IRB procedures must address informed consent forms, vulnerable populations, and monitoring plans consistent with guidance from organizations like the National Academies of Sciences, Engineering, and Medicine and the World Health Organization. Compliance programs often integrate policies from regulators including the Office of Inspector General (United States Department of Health and Human Services), the Equal Employment Opportunity Commission, and federal grant administrators at the National Science Foundation.

Ethical Principles and Protections for Human Subjects

The ethical framework embedded in 45 CFR 46 reflects principles articulated by the Belmont Report—respect for persons, beneficence, and justice—and protects categories such as children, prisoners, pregnant women, and cognitively impaired individuals, with procedural safeguards informed by cases and reports from institutions like the Institute of Medicine and decisions arising from incidents comparable to the Willowbrook State School investigations. The regulation shapes consent processes used in clinical trials sponsored by entities such as Pfizer, Moderna, GlaxoSmithKline, and academic studies at institutions like Stanford University and Massachusetts General Hospital, and it guides data protection and confidentiality practices in collaboration with standards from the National Institutes of Health and the International Conference on Harmonisation.

Enforcement, Waivers, and Amendments

Enforcement mechanisms include HHS oversight, suspension or termination of research approvals, and corrective actions coordinated with agencies like the Office for Civil Rights, the Department of Education, and the Food and Drug Administration when dual-jurisdiction issues arise. The regulation permits limited waivers and alterations of consent and IRB procedures under specified conditions, and it has been amended over time through rulemaking processes involving the Federal Register, public comment by stakeholders including academic societies and patient advocacy groups, and harmonization efforts with regulations like the Common Rule used by multiple federal agencies.

Category:United States administrative law